Royal London Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.2M | Sell |
577,485
-8,130
| -1% | -$656K | 0.08% | 190 |
|
|
2026
Q1 | $50.7M | Sell |
585,615
-1,621
| -0.3% | -$155K | 0.11% | 168 |
|
|
2025
Q4 | $56.4M | Sell |
587,236
-8,139
| -1% | -$791K | 0.12% | 155 |
|
|
2025
Q3 | $56.7M | Sell |
595,375
-13,840
| -2% | -$1.27M | 0.12% | 157 |
|
|
2025
Q2 | $53.1M | Sell |
609,215
-12,839
| -2% | -$1.09M | 0.12% | 156 |
|
|
2025
Q1 | $55.9M | Buy |
622,054
+61,640
| +11% | +$5.52M | 0.13% | 142 |
|
|
2024
Q4 | $44.8M | Sell |
560,414
-1,164
| -0.2% | -$101K | 0.11% | 155 |
|
|
2024
Q3 | $50.6M | Buy |
561,578
+8,907
| +2% | +$749K | 0.12% | 146 |
|
|
2024
Q2 | $43.5M | Sell |
552,671
-1,589
| -0.3% | -$130K | 0.11% | 154 |
|
|
2024
Q1 | $48.3M | Buy |
554,260
+11,278
| +2% | +$963K | 0.12% | 149 |
|
|
2023
Q4 | $44.7M | Buy |
542,982
+14,743
| +3% | +$1.12M | 0.13% | 144 |
|
|
2023
Q3 | $41.4M | Buy |
528,239
+11,113
| +2% | +$930K | 0.13% | 132 |
|
|
2023
Q2 | $45.5M | Buy |
517,126
+28,875
| +6% | +$2.49M | 0.15% | 127 |
|
|
2023
Q1 | $39.4M | Buy |
488,251
+7,505
| +2% | +$612K | 0.16% | 122 |
|
|
2022
Q4 | $37.4M | Buy |
480,746
+14,274
| +3% | +$1.16M | 0.17% | 123 |
|
|
2022
Q3 | $37.7M | Sell |
466,472
-27,608
| -6% | -$2.48M | 0.19% | 102 |
|
|
2022
Q2 | $44.4M | Buy |
494,080
+3,089
| +0.6% | +$313K | 0.21% | 99 |
|
|
2022
Q1 | $54.5M | Buy |
490,991
+14,949
| +3% | +$1.58M | 0.21% | 93 |
|
|
2021
Q4 | $49.2M | Sell |
476,042
-2,635
| -0.6% | -$305K | 0.18% | 104 |
|
|
2021
Q3 | $60M | Sell |
478,677
-12,545
| -3% | -$1.62M | 0.24% | 81 |
|
|
2021
Q2 | $61M | Hold |
491,222
| – | – | 0.25% | 85 |
|
|
2021
Q1 | $58.1M | Buy |
+491,222
| New | +$57.6M | 0.27% | 82 |
|
|
2019
Q4 | – | Sell |
-684,219
| Closed | -$74.3M | – | 652 |
|
|
2019
Q3 | $74.3M | Buy |
+684,219
| New | +$71.4M | 0.56% | 37 |
|
|
2019
Q2 | – | Sell |
-696,603
| Closed | -$63.5M | – | 622 |
|
|
2019
Q1 | $63.5M | Buy |
696,603
+18,407
| +3% | +$1.65M | 0.5% | 42 |
|
|
2018
Q4 | $60.5M | Buy |
+678,196
| New | +$63.4M | 0.53% | 38 |
|
|
2018
Q3 | – | Sell |
-575,553
| Closed | -$49.3M | – | 562 |
|
|
2018
Q2 | $49.3M | Buy |
+575,553
| New | +$48.1M | 0.5% | 42 |
|
|
2014
Q4 | $226K | Buy |
308,638
+71,616
| +30% | +$4.97M | 0.43% | 58 |
|
|
2014
Q3 | $14.8M | Buy |
237,022
+4,841
| +2% | +$308K | 0.37% | 66 |
|
|
2014
Q2 | $14.2M | Sell |
232,181
-1,040
| -0.4% | -$63.2K | 0.33% | 76 |
|
|
2014
Q1 | $14.2M | Sell |
233,221
-7,132
| -3% | -$415K | 0.33% | 78 |
|
|
2013
Q4 | $14.4M | Buy |
240,353
+2,383
| +1% | +$135K | 0.37% | 62 |
|
|
2013
Q3 | $13.7M | Buy |
237,970
+2,686
| +1% | +$145K | 0.37% | 63 |
|
|
2013
Q2 | $12.2M | Buy |
+235,284
| New | +$11.6M | 0.36% | 61 |
|
Other funds holding MDT
Royal London Asset Management's MDT Position: Q2 2026 in Review
Royal London Asset Management reduced its Medtronic (MDT) stake by 1.4% in Q2 2026, selling an estimated $656K and leaving 577,485 shares worth $45.2M. The position accounts for 0.08% of the portfolio, ranked #190.
Royal London Asset Management first reported a position in MDT in Q2 2013 and has held it in 33 quarters since. The position peaked at $74.3M in Q3 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Royal London Asset Management held 577,485 shares of Medtronic worth $45.2M as of Q2 2026.
- Royal London Asset Management sold 8,130 Medtronic shares in Q2 2026, an estimated $656K.
- Medtronic made up 0.08% of Royal London Asset Management's portfolio in Q2 2026, its #190 holding.
- Royal London Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 33 quarters since.
- Royal London Asset Management's Medtronic position peaked at $74.3M in Q3 2019.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.